Estrella Biopharma
About:
Estrella Biopharma develops transformative cancer medicines with CD19-Redirected ARTEMIS T Cells to improve patients’ lives.
Website: https://www.estrellabio.com/
Description:
Estrella Biopharma is a biotech firm that is dedicated to advancing cancer treatment with CD19-Redirected ARTEMIS T Cells, aiming to enhance patient outcomes. Leveraging recent breakthroughs in cell therapy, the company focuses on developing transformative medicines not only for hematological malignancies but also for solid tumors. Estrella Biopharma stands at the forefront of pioneering next-generation T-cell therapies, addressing treatment challenges across a spectrum of cancers.
$10M
$1M to $10M
Emeryville, California, United States
2022-01-01
11-50
2023-09-29
Public
© 2025 bioDAO.ai